好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Increased US Utilization of Thrombolysis in the Treatment of Stroke
Cerebrovascular Disease and Interventional Neurology
(-)
078
Authors/Disclosures
Richard M. Dubinsky, MD, MPH, FAAN (University of Kansas Medical Center) Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Neurocrine. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals.
Sue M. Lai, PhD (Univ of Kansas Med Ctr/Preventive Med) No disclosure on file
Carl Langefeld No disclosure on file